SCHEMBL17427862

SCHEMBL17427862

OC1CC2CC(C1)N2P

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13377142 0.73 LMNA (0.48)
SCHEMBL21882378 0.73 LMNA (0.48)
SCHEMBL14495177 0.73 LMNA (0.48)
SCHEMBL6745315 0.71
SCHEMBL25395371 0.63 CHRM2 (0.39)
SCHEMBL20974097 0.63 CHRM2 (0.39)
SCHEMBL26238392 0.63 LMNA (0.50)
SCHEMBL24174305 0.62
SCHEMBL11036944 0.62 LMNA (0.57)
SCHEMBL24995553 0.62 LMNA (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170210713-A1 PYRIMIDINE CARBOXAMIDES AS SODIUM CHANNEL BLOCKERS PURDUE PHARMA L.P. 2017-07-27 US disclosed
US-9637458-B2 Pyrimidine carboxamides as sodium channel blockers PURDUE PHARMA L.P. 2017-05-02 US disclosed
US-20160009659-A1 PYRIMIDINE CARBOXAMIDES AS SODIUM CHANNEL BLOCKERS PURDUE PHARMA L.P. 2016-01-14 US disclosed